These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9413813)

  • 1. Lactose intolerance following antithyroid drug medications.
    Petrini L; Usai P; Caradonna A; Cabula R; Mariotti S
    J Endocrinol Invest; 1997 Oct; 20(9):569-70. PubMed ID: 9413813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure.
    Macia M; Méndez M; Fernández J; Riverol A; Rios
    Clin Nephrol; 1997 Feb; 47(2):129. PubMed ID: 9049463
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antithyroid drugs in a single daily dose. Treatment of diffuse toxic goiter.
    Kammer H; Srinivasan K
    JAMA; 1969 Sep; 209(9):1325-7. PubMed ID: 4184703
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease.
    Bouma DJ; Kammer H; Greer MA
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1138-42. PubMed ID: 6182155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Side effects of antithyroid drugs].
    Shigemasa C; Noguchi T; Onoyama S; Okamura Y; Yoshida A; Mashiba H; Abe K
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1160-7. PubMed ID: 6689305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Childhood Graves' disease].
    Sasaki N; Sato K
    Nihon Rinsho; 2006 Dec; 64(12):2308-11. PubMed ID: 17154097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-galactosidase tablets in the treatment of lactose intolerance in pediatrics.
    Medow MS; Thek KD; Newman LJ; Berezin S; Glassman MS; Schwarz SM
    Am J Dis Child; 1990 Nov; 144(11):1261-4. PubMed ID: 2122719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithyroid drugs in practice.
    Vanderlaan WP
    Mayo Clin Proc; 1972 Dec; 47(12):962-5. PubMed ID: 4117991
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications.
    Smyczńyska J; Cyniak-Magierska A; Stasiak M; Karbownik-Lewińska M; Lewiński A
    Neuro Endocrinol Lett; 2014; 35(5):335-41. PubMed ID: 25275265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms.
    Montalto M; Gallo A; Santoro L; D'Onofrio F; Curigliano V; Covino M; Cammarota G; Grieco A; Gasbarrini A; Gasbarrini G
    Aliment Pharmacol Ther; 2008 Oct; 28(8):1003-12. PubMed ID: 18657134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.
    Greer MA; Kammer H; Bouma DJ
    N Engl J Med; 1977 Jul; 297(4):173-6. PubMed ID: 69269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there one successful antithyroid regimen for Graves' disease?
    Braverman LE
    Lancet; 1996 Sep; 348(9029):697-8. PubMed ID: 8806285
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactose intolerance: a non-allergic disorder often managed by allergologists.
    Perino A; Cabras S; Obinu D; Cavalli Sforza L
    Eur Ann Allergy Clin Immunol; 2009 Feb; 41(1):3-16. PubMed ID: 19496347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithyroid drugs.
    Goichot B; Vinzio S
    N Engl J Med; 2005 May; 352(21):2246-7; author reply 2246-7. PubMed ID: 15917394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.